Central and Peripheral Neuroendocrine Factors in Cancer-Associated Anorexia and Cachexia by Burgos, Jonathan R.
Central and Peripheral Neuroendocrine Factors in 
Cancer-Associated Anorexia and Cachexia 
AKADEMISK AVHANDLING 
Som för avläggande av medicine doktorsexamen vid Sahlgrenska akademin, Göteborgs 
universitet, kommer att offentligen försvaras i hörsal Arvid Carlsson 
Academicum Medicinaregatan 3 
Torsdagen den 17 december 2015 kl. 09:00 
av 
Jonathan R. Burgos 
Fakultetsopponent: Professor Per Hellström 
Institution för medicinska vetenskaper, Uppsala universitet 
Avhandlingen baseras på följande arbeten: 
I. Burgos JR, Iresjö B-M, Smedh U. Pituitary adenylate cyclase-activating 
polypeptide 6-38 blocks cocaine- and amphetamine-regulated transcript peptide-
induced hypophagia in rats. PLoS ONE 2013; 8(8): e72347. 
II. Burgos JR, Iresjö B-M, Wärnåker S, Smedh U. Presence of TSH receptors in 
discrete areas of the hypothalamus and brainstem with relevance for feeding 
controls—support for functional significance. Manuscript, submitted. 
III. Burgos JR, Iresjö B-M, Olsson L, Smedh U. Lipopolysaccharide immune 
challenge reduces TSHR and CART mRNA in the Arcuate nucleus and elevates 
circulating CART peptides in mice. Manuscript, submitted. 
IV. Burgos JR, Iresjö B-M, Smedh U. MCG101-induced cancer anorexia-cachexia 
features altered expression of hypothalamic Nucb2 and Cartpt and increased 
plasma levels of cocaine- and amphetamine-regulated transcript peptides. 
Oncology Reports, Accepted for publication 9 November 2015. 
V. Burgos JR, Iresjö B-M, Smedh U. PACAP6-38, a functional CARTp antagonist, 
counteracts loss of adipose tissue in MCG101 tumor-bearing mice with elevated 
host plasma CART and anorexia-cachexia syndrome. Manuscript. 
 
 
Göteborg 2015 
 
Central and Peripheral Neuroendocrine Factors in 
Cancer-Associated Anorexia and Cachexia 
Jonathan R. Burgos 
Department of Surgery, Institute of Clinical Sciences 
Sahlgrenska Academy at University of Gothenburg 
ABSTRACT 
Cancer anorexia-cachexia syndrome (CACS) develops in response to tumor-host biochemical interactions. 
A loss of appetite (anorexia) and increased metabolism results in a progressive wasting of adipose and 
skeletal muscle tissues (cachexia). This syndrome is linked to a reduced tolerance to anti-cancer treatments, 
lower quality of life, and poor prognosis. The specific mechanisms that cause CACS are still unknown, and 
there exists no curative treatment for this syndrome. In this thesis, rodent models for induced anorexia, 
MCG101 tumor-induced CACS, and acute inflammation paradigms were used.  
The first stages of this thesis project were aimed at identifying central mechanisms by which cancer-
associated anorexia could be overriding homeostatic feeding controls. Our initial investigations involved 
cocaine- and amphetamine-regulated transcript peptides (CARTp) and the thyrotropin receptor (TSHr). 
Centrally acting CARTp are known to potently inhibit feeding. Similarly, infusions of TSH into the lateral 
ventricles have been shown to reduce food intake in rats. The precise mechanisms through which CARTp 
elicits its effects, and the distribution of functional TSHr have been unknown. 
A previous in vitro study showed CARTp activity was antagonized by PACAP6-38. We built upon previous 
findings by showing that PACAP6-38 could block CARTp-induced anorexia in vivo in rats; thus, we 
provided further support that PACAP6-38 is a useful tool for elucidating endogenous CARTp effects. In 
addition, we report that TSHr proteins are present in nuclei of the hypothalamus and brainstem with 
relevance for feeding. Indeed, putative stimulation of TSHr in the nucleus of the solitary tract reduced solid 
food intake in healthy rats. 
Using mouse models for acute inflammation and CACS, we investigated gene expression changes in areas 
of the brain with relevance for feeding, namely the hypothalamic paraventricular nucleus (PVN), arcuate 
nucleus (ARC), and the dorsal vagal complex of the brainstem. We investigated mRNA for compounds 
expressed in brain regions involved in feeding behavior under healthy conditions: CART, TSHr, TSH, 
thyrostimulin, nesfatin-1, and corticotropin-releasing hormone (CRH). Acute inflammation was associated 
with reduced gene expression for TSHr and CART in the ARC and increased expression of CART mRNA 
in the pituitary. CACS also resulted in a decrease in CART gene expression in the PVN, which was a 
response secondary to reduced food intake as shown by pair-fed controls. Interestingly, we saw a tumor-
specific effect on nesfatin-1 gene expression in the PVN. Therefore, it appears that CARTp is not inducing 
anorexia in CACS, but seems to participate in an adaptive response. In addition, hypothalamic nesfatin-1 
may be a likely candidate for mediating a CACS response. 
Acute inflammation induced a prostanoid-independent increase of plasma CARTp, which correlated 
positively with degree of inflammation. Tumor-bearing mice similarly had elevated plasma CARTp 
concentrations. Putative antagonism of circulating CARTp by PACAP6-38 in tumor-bearing animals 
protected against loss of fat mass, but did not improve food intake or any other metrics. These findings 
highlight plasma CARTp as a potential mediator of lipolysis in CACS. 
 
Keywords: cancer anorexia-cachexia syndrome; MCG101; inflammation; CART; TSH receptor; CRH; nesfatin-1; 
hypothalamus; brainstem  
ISBN: 978-91-628-9613-3 (Printed); 978-91-628-9614-0 (Electronic Publication) 
Thesis frame available online at: http://hdl.handle.net/2077/40444 
